400-921-8278
| Catalog_no | ADMC0242 |
| Product_name | Tofacitinib (CP-690550) Citrate |
| Category | 抑制剂与激动剂 |
| Size | 10mg/50mg/100mg |
| Price | 560.00/880.00/1220.00 |
| Specificity | Target: JAK. Fields: Tofacitinib is a novel inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent versus JAK2 and JAK1. Phase 3. |
| Dilution | IC50: 1 nM (JAK3), 20 nM (JAK2), 112 nM (JAK1)[1] |
| Purification | >98% |
| Concentration | 靶点：JAK;IC50： 1 nM (JAK3), 20 nM (JAK2), 112 nM (JAK1)[1] |
| Storage_stability | 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername | CP-690550; Tofacitinib; tasocitinib |
| Observed_band | 504.49 |
| Notes | Tofacitinib is a novel inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent versus JAK2 and JAK1. Phase 3. |
| Instructions | 
查看与下载 |
| Share |
 |
Copyright © 2021 苏州博特龙免疫技术有限公司 版权所有 ，苏ICP备2021013855号-1
苏公网安备32050702011981号 
